INTRODUCTION
We have found specific inhibitors of various enzymes that can be used as important tools for elucidating different disease processes and are potentially useful in the treatment of diseases (1-4).
Ala-NA, L-Ser-NA, L-Leu-NA.HCl, L-Phe-NA, L-Trp-NA, Gly-L-Pro-NA, L-Ser-L-Tyr-NA, and acetyl-L-alanyl-L-alanyl-Lalanine methyl ester (Ac(Ala)3ME) from Bachem Feinchemikalien AG, Schweiz; p-tolue nesulfonyl-L-arginine methyl ester hydrochloride (TAME), N-acetyl-L-tyrosine ethyl ester (ATEE), and p-nitrophenyl acetate (NPA) from Tokyo Kasei Kogyo Co., Japan; p-nitrophenyl-a-D-glucopyranoside (NP-Glc), p-nitrophenyl-a-D-mannopyranoside (NP-Man), and hemoglobin from Calbiochem-Behring Corp., San Diego, Calif.; p-nitrophenyl-,/3D-galactopyranoside (NP-Gal), p-nitrophenyl-N-acetyl-,8-D-glucosaminide (NP-AG), and p-nitrophenyl phosphate (NPP) from BDH Chemicals Ltd., England; RNA from Boehringer Mannheim, West Germany. Formyl L-methionine j8-naphthylamide (f.Met-NA) and Gly-His-Lys were kindly synthesized by Dr. H. Suda and Dr. T. Yoshioka in our institute.
Determination of enzyme activities. The supernatant fluids of homogenates were dispensed into test tubes (1.5 x 10 cm) with buffer containing the respective substrates. The test tubes were incubated for 1 h at 370C. For the aminopeptidase (AP) assay, 0.25 ml of 2.0 mM f8-naphthylamide derivative was used as the substrate. After the reaction, 1.0 ml of a solution of the stabilized diazonium salt Garnet GBC (1 mg/ml, in 1 M acetic-acid buffer at pH 4.2, containing 10% Tween 20) was added, and the mixture kept for 15 min at room temperature; the absorbance at 525 nm was determined (17) . For the endopeptidase assay, 0.1 ml of 75 mM ester of peptide or N-acylaminoacid was used as the substrate; after the reaction, 2.0 ml of alkaline hydroxylamine solution (2 M hydroxylamine.HCl mixed with equal volume of 3.5 N NaOH) was added, and the mixture kept for 30 min at room temperature. 1.0 ml of 12% hydrochloric acid solution containing trichloracetic acid at 6% was added. 1 ml of this solution was added to 4.0 ml of ferric chloride (0.11 M) in 0.04 N HCI and the absorbance at 525 nm was measured (18) . For the cathepsin-D assay, 1.0 ml of 0.5% hemoglobin solution (pH 2.0) was used as the substrate. 2.0 ml of 1.7 M perchloric acid was added after the reaction, and the mixture was kept for 1 h at room temperature. The supernatant fluid was withdrawn by centrifugation (3,000 rpm, 5 min) and the absorbance at 280 nm was determined (19) . For the glycosidase assay, 0.05 ml of 50 mM p-nitrophenyl derivative was used as the substrate. The reaction was terminated by the addition of 0.2 ml of 0.4 M glycine-NaOH buffer (pH 10.5), and the mixture was centrifuged at 3,000 rpm for 5 min. The supernatant fluid was withdrawn and the absorbance at 400 nm was determined (20) . For phosphatase and esterase assay, 0.03 ml of 50 mM p-nitrophenyl derivative was used as the substrate. After the reaction, the mixture was processed in a way similar to the glycosidase assay. The absorbance was measured at 420 nm for the phosphatase assay, and at 400 nm for the esterase assay (21) . For RNase assay, a slight modification of the method of Meyer et al. (22) was used. 0.25 ml of 2% RNA from yeast with or without p-hydroxymercuriphenylsulfonate was used as the substrate to measure the activities of free and total RNase, respectively. After the reaction at pH 7.6, 0.5 ml of stop solution (uranyl acetate 0.75% in 25% perchloric acid) was added and the mixture kept for 1 h in ice water. The supernatant fluid was withdrawn by centrifugation, and the absorbance at 260 nm was measured. Free RNase activity is defined as activity measured without p-hydroxymercuriphenylsulfonate, and total RNase is the activity measured with this agent. According to Meyer et al. (22) , the latter is considered to include free RNase and RNase bound to an intrinsic inhibitor.
Protein determination. Fig. lb , AP activities in the homogenate were linear with respect to the protein concentration in the assay medium, which was used as an index of the enzymes contained. All other assays were similarly linear with time and enzyme concentrations. All the enzyme assays were done in triplicate and their errors were within 10% of the average values.
To assess the behavior of each enzyme, statistical analysis was done with respect to activities of the 27 kinds ofenzyme in muscle and in bone (Tables I and II) . In this case, the enzyme activity is expressed in nanomolars of reaction products per minute per 1 g wet wt of organs. The activities for the fore limbs and the hind limbs of both sexes were combined. This treatment can be justified from the similarity of their enzyme activities. In muscle, most significant increases were seen in the activities of Gly-AP, Met-AP, Phe-AP, Trp-AP, Gly-Pro-Leu-AP, GlyHis-Lys-AP, cathepsin C, a-D-glucosidase, N-Ac-(3-D-glucosaminidase, free RNase, and total RNase (P < 0.001). The increased activity of AP-A, Ala-AP, Ser-AP, Leu-AP, Gly-Pro-AP, chymotrypsin-like enzyme, and ,8-D-galactosidase were highly significant (P < 0.01).
Significant increases were also seen in the activity of a-D-mannosidase (P < 0.05). Possibly significant increases were seen in the activities of elastaselike enzyme and esterase (P <0.1). Only trypsinlike enzyme activity tended to decrease in dystrophic mice, although this decrease was not statistically significant.
The remaining four kinds of enzymes tended to increase but without statistical significance. In bone, most significant increases were seen in the activities of Ala-AP, Phe-AP, Trp-AP, free RNase, and total RNase (P < 0.001). Highly significant increases were seen in those of AP-A, AP-B, Gly-AP, Ser-AP, Leu-AP, Met-AP, Gly-Pro-Leu-AP, chymotrypsinlike enzymes, and N-Ac-f3-D-glucosaminidase (P < 0.01).
Significant increases were seen in the activities of Gly-Pro-AP, Gly-His-Lys-AP, trypsinlike enzyme, cathepsin C, cathepsin D, and esterase (P < 0.05). Possibly significant increases were seen in the activities of f.Met-AP, a-D-mannosidase, and phosphatase (P<0.1).
In Tables III and IV , the activities are expressed in terms of specific activity per minute per milligram of protein in organs. In muscle, the most significant differences in activity were seen with Gly-AP, Ala-AP, Leu-AP, Met-AP, Phe-AP, Trp-AP, Gly-His-Lys-AP, N-Ac-,8-D-glucosaminidase, and free RNase (P < 0.001).
Highly significant differences were seen with AP A, cathepsin C, a-D-galactosidase, and total RNase (P < 0.01). A significant difference was seen in the activities of Ser-AP, Gly-Pro-Leu-AP, cathepsin D, /-Dgalactosidase, a-D-mannosidase, and esterase (P < 0.05).
Biochemists Table I. in tissues can influence this parameter, regardless of enzyme content in the tissues. Hence we present not only Tables III and IV but also Tables I and II. Comparing the results in Tables I and II with those in  Tables III and IV Table V , the slope of regression lines was generally >1 .0 for most organs tested. The correlation coefficients were very high, ranging from 0.80 to 0.99 (P < 0.001). The intercepts on the ordinate (Y-axis) were relatively small for all cases. Table V also includes the results of the Student's paired t test. As can be seen, aminopeptidases significantly increased in most organs of dystrophic mice. Spleen, stomach, lung, and uterus did not show significant changes. It was only in the thymus that a highly significant decrease of aminopeptidases was seen. In muscle, bone, heart, submaxillary gland, pancreas, liver, brain, and testis, the increases of the enzymes were significant.
In Fig. 4 , these regression lines are displayed together. It is clear that the lines representing most organs, except thymus, lung, and stomach, run above the unity lines with a 450 slope. Hence, it seems reasonable that the production of aminopeptidases is increased in the whole body of dystrophic mice. Fig. 3 . Most of the circles a unity line, suggesting that the protein me in dystrophic mice. The difference bets control animals was statistically sign Student's paired t test (P < 0.05 for ma female). muscular dystrophy (5-11). Sanada The reason we separated fore limbs and hind limbs was that hind limbs are known to be affected first by the trol and dystrophy, of disease. However, we did not find any particular diffigure are the same ference between these, as far as the enzyme contents Ire located above the are concerned. Although it would have been more Ltabolism is abnormal useful to compare red and white muscles, it was not ween dystrophic and possible for us to separate these in dystrophic mice, ificant according to ile and P < 0.005 for because of the atrophy of muscle. This trial iS being done in our study on chicken muscle dystrophy.
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T. Aoyagi, T. Wada, F. Kojima, M. Nagai, and H. Umezawa Gly-Pro-AP, (13) Gly-Pro-Leu-AP, (14) Gly-His-Lys-AP. Most of the closed and open circles are along a regression line, meaning that the changes of these aminopeptidases are somehow correlated with each other.
Many aminopeptidase activities were found to be remarkably increased in dystrophic mice. So far, most of the aminopeptidases have not been fully isolated and their properties are little understood. Our method of assessing the activity of these enzymes using ,3-NA may be limited in its specificity, because it is possible that an AP could hydrolyze several kinds of 8-NA. However, according to our previous studies, AP-B, AP-A and f.Met-AP purified by the affinity chromatography using aminopeptidase inhibitors, bestatin and amastatin, show relatively high substrate specificity against their corresponding /3-naphthylamide, Arg-NA, Asp-NA and f.Met-AP (25) .2 As we have reported (21, 26, 27) , the activities of several aminopeptidases have been found in the membrane fraction of all kinds ofcells tested, and AP-A was suggested to be one ofthe transformation-sensitive proteins. Considering these observations, the observed increase ofaminopeptidases in many organs of dystrophic mice should be very important.
In addition to aminopeptidases, many other enzyme activities were increased in dystrophic mice. Moreover, these abnormalities were not limited to muscle but widely distributed in the whole body. At the present time, we have no precise data concerning the subcellular source of the enzymes we tested. A large part of these enzymes probably come from lysosomes. However, we previously demonstrated aminopeptidases, phosphatase, and esterase on cellular membranes of various organs (21, 27) . It is evident that more studies need to be done using subcellular fractions of these organs. It is also noteworthy that protein content per unit wet weight of organs was si increased in many organs examined in dystr This observation may seem odd, since many studies reported an extensive loss of conti tein in diseased muscle. However, there studies reporting an increased rate of proteii in dystrophic muscle that is seemingly iI with muscle wasting (28) . Because the loss could arise from either an increased rate c tion or a decreased rate of protein synthes content should be dependent on the incre tein catabolism and increase of protein causing a faster turnover. Protein content of dystrophic animals may be different, on the stage of disease and the animal mod
The present study suggests extensive abi in enzyme activities associated with met carbohydrate, protein, and RNA in this condition. Several endopeptidase inhibitor our laboratory have been used to suppress degeneration in muscular dystrophy, and so endorsed the usefulness of leupeptin, antip 9 12 6,7 pepstatin for this purpose (5, 6). However, it does not 14 
